|
Volumn 9, Issue 1, 2014, Pages
|
Increased HEV seroprevalence in patients with autoimmune hepatitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
CYCLOSPORIN;
HEPATITIS E ANTIBODY;
PREDNISOLONE;
VIRUS RNA;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ARTICLE;
AUTOIMMUNE HEPATITIS;
CELL PROLIFERATION;
CONTROLLED STUDY;
DRUG DOSE REDUCTION;
DRUG INDICATION;
DRUG USE;
FEMALE;
HEPATITIS B;
HEPATITIS C;
HEPATITIS E;
HEPATITIS E VIRUS;
HUMAN;
IMMUNE RESPONSE;
IMMUNOCOMPROMISED PATIENT;
IN VITRO STUDY;
MAJOR CLINICAL STUDY;
MALE;
NONHUMAN;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
SEROPREVALENCE;
T LYMPHOCYTE;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ARTHRITIS, RHEUMATOID;
CASE-CONTROL STUDIES;
COINFECTION;
FEMALE;
HEPATITIS ANTIBODIES;
HEPATITIS B;
HEPATITIS C;
HEPATITIS E;
HEPATITIS E VIRUS;
HEPATITIS, AUTOIMMUNE;
HEPATITIS, CHRONIC;
HUMANS;
IMMUNOCOMPROMISED HOST;
MALE;
MIDDLE AGED;
RNA, VIRAL;
SEROEPIDEMIOLOGIC STUDIES;
T-LYMPHOCYTES;
|
EID: 84904914693
PISSN: None
EISSN: 19326203
Source Type: Journal
DOI: 10.1371/journal.pone.0085330 Document Type: Article |
Times cited : (66)
|
References (27)
|